Hongli Gao

Shenyang, 110022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer.

Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer.

Journal: Molecular cancer

Published: April 14, 2025

USPs and non-coding RNAs: Unraveling their interplay within tumor microenvironment for targeted cancer therapy.

USPs and non-coding RNAs: Unraveling their interplay within tumor microenvironment for targeted cancer therapy.

Journal: Pharmacological research

Published: March 23, 2025

Unlocking the potential of chimeric antigen receptor T cell engineering immunotherapy: Long road to achieve precise targeted therapy for hepatobiliary pancreatic cancers.

Unlocking the potential of chimeric antigen receptor T cell engineering immunotherapy: Long road to achieve precise targeted therapy for hepatobiliary pancreatic cancers.

Journal: International journal of biological macromolecules

Published: October 27, 2024

Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options.

Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options.

Journal: Molecular cancer

Published: February 03, 2024

Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer.

Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer.

Journal: Molecular cancer

Published: January 05, 2024

Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment.

Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: August 29, 2023

Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application.

Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 10, 2023

CMTM6 as a potential therapy target is associated with immunological tumor microenvironment and can promote migration and invasion in pancreatic adenocarcinoma.

CMTM6 as a potential therapy target is associated with immunological tumor microenvironment and can promote migration and invasion in pancreatic adenocarcinoma.

Journal: Functional & integrative genomics

Published: April 12, 2023

CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer.

CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer.

Journal: Molecular cancer

Published: December 05, 2022

A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma.

A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma.

Journal: BMC medical informatics and decision making

Published: April 05, 2022

Showing 1-10 of 10

Last Updated: 09/26/2026